Chenomx offers a proprietary platform for generating, classifying, and interpreting metabolic information obtained from biological fluids using nuclear magnetic resonance (NMR) spectroscopy. Chenomx combines state-of-the-art spectroscopic technology for identifying metabolic markers with advanced algorithms for analyzing biological samples. Chenomx's technology platform is available through software licensing. (Bio AB)